Nanoclay Reinforced Ternary Blends Based on Biodegradable Polymers for Drug Delivery Application.

IF 3 Q3 MATERIALS SCIENCE, BIOMATERIALS
International Journal of Biomaterials Pub Date : 2022-09-07 eCollection Date: 2022-01-01 DOI:10.1155/2022/6585305
Mohsin Ali, Sadullah Mir, Obaid-Ur-Rahman Abid, Mirza Arfan Yawer, Ihsan Ullah
{"title":"Nanoclay Reinforced Ternary Blends Based on Biodegradable Polymers for Drug Delivery Application.","authors":"Mohsin Ali,&nbsp;Sadullah Mir,&nbsp;Obaid-Ur-Rahman Abid,&nbsp;Mirza Arfan Yawer,&nbsp;Ihsan Ullah","doi":"10.1155/2022/6585305","DOIUrl":null,"url":null,"abstract":"<p><p>In this study, ternary blends based on chitosan, polyvinyl alcohol, and polyethylene glycol reinforced with organically modified montmorillonite (nanoclay) clay were synthesized. These ternary blends were evaluated as transdermal drug delivery patches using tramadol as a model drug. The FTIR study showed interaction among important functional groups and compatibility among the mixing components. Among drug-loaded formulations, composite MA12 shows maximum thermal stability with 27.9% weight residue at 540°C. The prepared formulations exhibited crystalline nature as observed by XRD analysis. SEM studies revealed that there are no gaps and cracks in prepared films and nanoclay was found dispersed in the formulations. The swelling ratio was higher in pH 1.2 as compared to pH 4.5 and pH 6.8 buffers, and there was an increase in swelling with an increase in PVA concentration. Moreover, the drug release test performed in phosphate buffer pH 6.8 showed that tramadol release from nanocomposite films increases with an increase in PEG concentration. Permeation studies indicated that the rate of permeation increased with a decrease in PVA concentration. The permeation rate was found to be higher for samples without nanoclay. The overall results suggest nanocomposite films as excellent candidates for transdermal drug delivery application.</p>","PeriodicalId":13704,"journal":{"name":"International Journal of Biomaterials","volume":" ","pages":"6585305"},"PeriodicalIF":3.0000,"publicationDate":"2022-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473880/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biomaterials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/6585305","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 1

Abstract

In this study, ternary blends based on chitosan, polyvinyl alcohol, and polyethylene glycol reinforced with organically modified montmorillonite (nanoclay) clay were synthesized. These ternary blends were evaluated as transdermal drug delivery patches using tramadol as a model drug. The FTIR study showed interaction among important functional groups and compatibility among the mixing components. Among drug-loaded formulations, composite MA12 shows maximum thermal stability with 27.9% weight residue at 540°C. The prepared formulations exhibited crystalline nature as observed by XRD analysis. SEM studies revealed that there are no gaps and cracks in prepared films and nanoclay was found dispersed in the formulations. The swelling ratio was higher in pH 1.2 as compared to pH 4.5 and pH 6.8 buffers, and there was an increase in swelling with an increase in PVA concentration. Moreover, the drug release test performed in phosphate buffer pH 6.8 showed that tramadol release from nanocomposite films increases with an increase in PEG concentration. Permeation studies indicated that the rate of permeation increased with a decrease in PVA concentration. The permeation rate was found to be higher for samples without nanoclay. The overall results suggest nanocomposite films as excellent candidates for transdermal drug delivery application.

Abstract Image

Abstract Image

Abstract Image

基于可生物降解聚合物的纳米粘土增强三元共混物的药物传递应用。
本研究以壳聚糖、聚乙烯醇和聚乙二醇为基础,用有机改性蒙脱土(纳米粘土)增强三元共混物。以曲马多为模型药物,对这些三元共混物作为透皮给药贴剂进行了评价。FTIR研究表明,重要官能团之间存在相互作用,混合组分之间存在相容性。在载药制剂中,复合MA12在540℃时的热稳定性最高,残留量为27.9%。XRD分析表明,所制备的配方具有结晶性。扫描电镜研究表明,制备的薄膜中没有缝隙和裂缝,纳米粘土分散在配方中。与ph4.5和ph6.8缓冲液相比,ph1.2缓冲液的溶胀率更高,并且随着PVA浓度的增加,溶胀率增加。此外,在pH为6.8的磷酸盐缓冲液中进行的药物释放试验表明,随着PEG浓度的增加,纳米复合膜的曲马多释放量增加。渗透研究表明,随着PVA浓度的降低,渗透速率增加。不含纳米粘土的样品的渗透速率更高。综上所述,纳米复合膜是经皮给药的理想候选材料。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Biomaterials
International Journal of Biomaterials MATERIALS SCIENCE, BIOMATERIALS-
CiteScore
4.30
自引率
3.20%
发文量
50
审稿时长
21 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信